The global Nutraceutical Ingredients market was valued at USD 29.87 billion in 2016 and is projected to reach USD 56.31 billion by 2025, growing at a CAGR of 7.3% from 2017 to 2025.
Nutraceuticals are experiencing huge demand owing to the growing trend of self nutrition. The rising health awareness among the population is a major market drivers for nutraceutical. The growing demand for nutraceuticals is having a positive impact on market demand for nutraceutical ingredients. The growing concerns regarding regulations about ingredients used in the manufacturing of these products is expected to have a negative impact on market demand.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growth in life expectancy & health consciousness among consumers
1.2 Increase in applications of nutraceutical ingredients
2. Market Restraints
2.1 High costs involved in R & D activities
Market Segmentation:
The global Nutraceutical Ingredients market is segmented on the product, application, health benefit, and region.
1. By Product:
1.1 Proteins and Amino acids
1.2 Prebiotics
1.3 Probiotics
1.4 Minerals
1.5 Carotenoids
1.6 Fibers and Specialty Carbohydrates
1.7 Vitamins
1.8 Omega-3 Fatty Acids
1.9 Phytochemicals and Plant Extracts
1.10 Others
2. By Application:
2.1 Animal Nutrition
2.2 Dietary Supplements
2.3 Functional Beverages
2.4 Functional Foods
2.5 Personal Care
2.6 Animal Nutrition
3. By Health Benefit:
3.1 Heart Health
3.2 Gut Health
3.3 Bone Health
3.4 Nutrition
3.5 Immunity
3.6 Weight Management
3.7 Others
4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Ajinomoto Inc.
2. Cargill
3. Archer Daniels Midland Company
4. BASF SE
5. Associated British Foods
6. Ingreidon
7. Koninjklike DSM NV
8. Arla Foods
9. Tate and Lyle PLC
10. EI Du Pont De Nemours
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Nutraceutical Ingredients market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL NUTRACEUTICAL INGREDIENTS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY PRODUCT
5.1 Overview
5.2 Proteins and Amino acids
5.3 Prebiotics
5.4 Probiotics
5.5 Minerals
5.6 Carotenoids
5.7 Fibers and Specialty Carbohydrates
5.8 Vitamins
5.9 Omega-3 Fatty Acids
5.10 Phytochemicals and Plant Extracts
5.11 Others
6 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION
6.1 Overview
6.2 Animal Nutrition
6.3 Dietary Supplements
6.4 Functional Beverages
6.5 Functional Foods
6.6 Personal Care
6.7 Animal Nutrition
7 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY HEALTH BENEFIT
7.1 Overview
7.2 Heart Health
7.3 Gut Health
7.4 Bone Health
7.5 Nutrition
7.6 Immunity
7.7 Weight Management
7.8 Others
8 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Ajinomoto Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Cargill
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Archer Daniels Midland Company
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 BASF SE
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Associated British Foods
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Ingredion
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Koninjklike DSM NV
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Arla Foods
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Tate and Lyle PLC
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 EI Du Pont De Nemours
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Reports